ELDN – eledon pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) market cap dropped US$48m last week; individual investors who hold 57% were hit as were institutions [Yahoo! Finance]
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results [Yahoo! Finance]
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
Form SC 13G/A Eledon Pharmaceuticals, Filed by: ARMISTICE CAPITAL, LLC
Form 10-Q Eledon Pharmaceuticals, For: Sep 30
Form 8-K Eledon Pharmaceuticals, For: Nov 12
Form SC 13G Eledon Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Form SC 13G Eledon Pharmaceuticals, Filed by: Frazier Life Sciences Public Fund, L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.